- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Quality of Care in Rheumatoid Arthritis
Call for Papers
Rheumatoid Arthritis (RA) represents a systemic inflammatory disease of varying severity that is responsible for pain, disability, absenteeism from work, and even death. Over the past decade, the increased use of magnetic resonance imaging (MRI) and the availability of biologic therapies have led to a drastic improvement in the quality of care in patients with RA even in cases considered before to be refractory. At the same time, the concept of “early arthritis” gave hope by concentrating on early diagnosis, early staging of the disease, and rapid institution of aggressive therapy.
As recently reported, a significant shorter time between RA diagnosis and disease modifying antirheumatic drugs (DMARDs)/biologic agents initiation suggests an advancement in disease control and improvement in quality of care.
However, growing demand for health care, rising costs, scarcity of resources, and presence of variations in clinical practice increased the interest in establishing new means by which one can measure the quality of health care and try to improve it. Unfortunately, varying assets available for different countries resulted in the creation of regional guidelines aiming to help physicians adjust their prescriptions according to patients’ capacity
RA patients are at increased risk of cardiovascular events than the general population; thus, every single patient should receive a cardiovascular evaluation and be started on therapy when appropriate.
We invite authors to submit original research and review articles that seek to elaborate on the above-mentioned aspects of RA. We are interested in articles that explore different features of quality of care (in terms of diagnosis, treatment, comorbidities, and socioeconomic status) in RA patients. Potential topics include, but are not limited to:
- The importance of early diagnosis and treatment
- Elucidating the prognostic factors of early arthritis and leading to more aggressive therapies
- Determining which biologic agent is superior in different individual cases along with provided interpretation
- Comparing different biologic agents in terms of safety and efficacy
- Does achieving remission have positive impact on cardiovascular risks?
- How do the regional guidelines affect the attitude of the clinician?
Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/rheumatology/qcra/ according to the following timetable:
|Manuscript Due||Friday, 14 February 2014|
|First Round of Reviews||Friday, 9 May 2014|
|Publication Date||Friday, 4 July 2014|
Lead Guest Editor
- Matteo Colina, Ospedale Santa Maria della Scaletta, Imola, Bologna, Italy